Blood-tumor barrier organoids recapitulate glioblastoma microenvironment and enable high-throughput modeling of therapeutic delivery DOI Open Access
Pei Zhuang, Benjamin B. Scott, Shuai Gao

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 12, 2024

The blood-brain barrier (BBB) is a highly specialized system that critical for regulating transport between the blood and central nervous system. In brain tumors, vasculature compromised, referred to as blood-tumor (BTB). ability precisely model unique physiological properties of BTB essential decipher its role in tumor pathophysiology rational design efficacious therapeutics. Here, we introduce robust high-throughput vitro 3D human organoid recapitulates various key features observed vivo clinical GBM samples. organoids are composed patient-derived glioblastoma stem cells (GSCs), endothelial (EC), astrocytes pericytes, which formed through self-assembly. Transcriptomic functional analyses reveal GSCs exhibit enhanced level stemness, mesenchymal signature, invasiveness angiogenesis, this further confirmed studies. We demonstrate therapeutic delivery drug efficacy on cells. Collectively, our findings show has broad utility clinically representative studying evaluating therapies.

Language: Английский

EPHB2 as a key mediator of glioma progression: Insights from microenvironmental receptor ligand-related prognostic gene signature DOI Creative Commons

Liming Tan,

Jingyuan Zhou,

Zhenyu Nie

et al.

Genomics, Journal Year: 2024, Volume and Issue: 116(3), P. 110799 - 110799

Published: Jan. 28, 2024

Malignant gliomas, characterized by pronounced heterogeneity, a complex microenvironment, and propensity for relapse drug resistaniguree, pose significant challenges in oncology. This study aimed to investigate the prognostic value of Ligand Receptor related genes (LRRGs) within glioma microenvironment. An intersection 71 ligand-related (LRGs) 2628 receptor-related (RRGs) yielded total 69 LRRGs. Utilizing least absolute shrinkage selection operator (LASSO) regression analysis, RiskScore model comprising 28 LRRGs was constructed. The demonstrated robust value, further validated TCGA-GBMLGG dataset. Subsequent analyses included differential gene expression, Gene Ontology (GO), Kyoto Encyclopedia Genes Genomes (KEGG), set enrichment (GSEA), variation (GSVA) groups. Additionally, evaluations PPI, mRNA-RBP, mRNA-TF, mRNA-drug interaction networks were conducted. Four hub identified through expression analysis across various GSE datasets. A multivariate Cox constructed nomogram mutation distribution. underscores role intercellular communication microenvironment identifies four crucial assessment clinical patients. These findings offer potential evaluation framework patients, enhancing our understanding disease informing future therapeutic strategies.

Language: Английский

Citations

0

The anti-angiogenic and anti-vasculogenic mimicry effects of GN25 in endothelial and glioma cells DOI
Zhi‐Hong Wen, Long Chang, San‐Nan Yang

et al.

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Journal Year: 2024, Volume and Issue: 1871(7), P. 119799 - 119799

Published: July 21, 2024

Language: Английский

Citations

0

Analysis of transcription profiles for the identification of master regulators as the key players in glioblastoma DOI Creative Commons
Sergey M. Ivanov, Alexey A. Lagunin, Olga Tarasova

et al.

Computational and Structural Biotechnology Journal, Journal Year: 2024, Volume and Issue: 23, P. 3559 - 3574

Published: Sept. 28, 2024

Language: Английский

Citations

0

KHDRBS3 facilitates self-renewal and temozolomide resistance of glioblastoma cell lines DOI

Kanokkuan Somrit,

Sucheewin Krobthong, Yodying Yingchutrakul

et al.

Life Sciences, Journal Year: 2024, Volume and Issue: unknown, P. 123132 - 123132

Published: Oct. 1, 2024

Language: Английский

Citations

0

Blood-tumor barrier organoids recapitulate glioblastoma microenvironment and enable high-throughput modeling of therapeutic delivery DOI Open Access
Pei Zhuang, Benjamin B. Scott, Shuai Gao

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 12, 2024

The blood-brain barrier (BBB) is a highly specialized system that critical for regulating transport between the blood and central nervous system. In brain tumors, vasculature compromised, referred to as blood-tumor (BTB). ability precisely model unique physiological properties of BTB essential decipher its role in tumor pathophysiology rational design efficacious therapeutics. Here, we introduce robust high-throughput vitro 3D human organoid recapitulates various key features observed vivo clinical GBM samples. organoids are composed patient-derived glioblastoma stem cells (GSCs), endothelial (EC), astrocytes pericytes, which formed through self-assembly. Transcriptomic functional analyses reveal GSCs exhibit enhanced level stemness, mesenchymal signature, invasiveness angiogenesis, this further confirmed studies. We demonstrate therapeutic delivery drug efficacy on cells. Collectively, our findings show has broad utility clinically representative studying evaluating therapies.

Language: Английский

Citations

0